Acrodermatitis Continua of Hallopeau Evolving into Generalized Pustular Psoriasis Following COVID‐19: A Case Report of a Successful Treatment with Infliximab in Combination with Ac...

par Samotij D, Gawron E, Szczęch J, Ostańska E, Reich A
Publié 2021

Editorial: Game Changers in Inflammatory Bowel Diseases

par Anita Bálint, Barbara Dorottya Lovász
Publié 2021

Has infliximab influenced the course and prognosis of acute severe ulcerative colitis?

par Viscido A, Papi C, Latella G, Frieri G
Publié 2019

An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis

par Chimenti MS, D'Antonio A, Conigliaro P, Ferrigno S, Vendola A, Ferraioli M, Triggianese P, Costa L, Caso F, Perricone R
Publié 2020

Biologic Treatments of Psoriasis: An Update for the Clinician

par Brownstone ND, Hong J, Mosca M, Hadeler E, Liao W, Bhutani T, Koo J
Publié 2021

Pharmacotherapy of inflammatory bowel diseases: efficacy performance and safety management

par Igor G. Bakulin, Maria I. Skalinskaya, Igor V. Maev, Ekaterina V. Skazyvaeva, Mariia S. Zhuravleva, Larisa B. Gaikovaya, Natalia V. Bakulina, Aleksei I. Ermakov, Ekaterina S. Alekseenko, Kristina N. Ivanova, Mikhail V. Solovev
Publié 2021